(FDA: Dallas, Texas) -- The U.S. Food and Drug Administration (FDA) Dallas District, in cooperation with the Society of Clinical Research Associates (SoCRA), is holding a conference on FDA Clinical Trial Requirements Regulations, Compliance, and GCP. This two-day program for the clinical research community targets sponsors, monitors, clinical investigators, institutional review boards, and those who interact with them for the purpose of conducting FDA-regulated clinical research. The program will include both industry and FDA perspectives on proper conduct of clinical trials regulated by the FDA.

This public conference is scheduled for Nov. 19–20, 2008, from 8 a.m. to 5 p.m. in Kansas City, Missouri.

For further information, visit www.socra.org/html/FDA_Conference.htm.

 …